Quest Diagnostics Inc (DGX): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2010-12-31, 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$11.04B
Year ended 2025-12-31
$11.56B
Trailing 12 months to 2026-06-30
+3.7%
3-year compound annual growth
+3.2%
5-year compound annual growth
2007-12-31: $6.70B2008-12-31: $7.25B2009-12-31: $7.46B2010-12-31: $7.26B2011-12-31: $7.39B2012-12-31: $7.38B2013-12-31: $7.15B2014-12-31: $7.43B2015-12-31: $7.49B2016-12-31: $7.21B2017-12-31: $7.40B2018-12-31: $7.53B2019-12-31: $7.73B2020-12-31: $9.44B2021-12-31: $10.79B2022-12-31: $9.88B2023-12-31: $9.25B2024-12-31: $9.87B2025-12-31: $11.04B$11.04B
2007-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$11.04B+11.8%2026-02-26, From 2025-01-01
2024-12-31$9.87B+6.7%2026-02-26, From 2024-01-01
2023-12-31$9.25B-6.4%2026-02-26, From 2023-01-01
2022-12-31$9.88B-8.4%2025-02-20, From 2022-01-01
2021-12-31$10.79B+14.3%2024-02-22, From 2021-01-01
2020-12-31$9.44B+22.1%2023-02-21, From 2020-01-01
2019-12-31$7.73B+2.6%2022-02-28, From 2019-01-01
2018-12-31$7.53B+1.7%2021-02-22, From 2018-01-01
2017-12-31$7.40B+2.6%2020-02-20, From 2017-01-01
2016-12-31$7.21Bn/c2019-02-21, From 2016-01-01
2015-12-31$7.49B+0.8%2018-02-23, From 2015-01-01
2014-12-31$7.43B+4.0%2017-02-22, From 2014-01-01
2013-12-31$7.15B-3.2%2016-02-26, From 2013-01-01
2012-12-31$7.38B-0.1%2015-02-24, From 2012-01-01
2011-12-31$7.39B+1.8%2014-02-18, From 2011-01-01
2010-12-31$7.26Bn/c2013-02-27, From 2010-01-01
2009-12-31$7.46B+2.8%2012-02-16, From 2009-01-01
2008-12-31$7.25B+8.1%2011-02-16, From 2008-01-01
2007-12-31$6.70Bn/a2010-02-17, From 2007-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$11.04B+11.8%
Labcorp Holdings Inc. (LH)2025-12-31$13.95B+7.2%
Fortrea Holdings Inc. (FTRE)2025-12-31$2.72B+1.0%
Natera, Inc. (NTRA)2025-12-31$2.31B+35.9%
RadNet, Inc. (RDNT)2025-12-31$2.04B+11.5%
Guardant Health, Inc. (GH)2025-12-31$982.02M+32.9%
Caris Life Sciences, Inc. (CAI)2025-12-31$812.03M+97.0%
Veracyte, Inc. (VCYT)2025-12-31$517.14M+16.0%
CareDx, Inc. (CDNA)2025-12-31$379.81M+13.8%

Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗